Literature DB >> 33952635

Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.

Breanna Tercero1, Krishna Narayanan1, Kaori Terasaki1,2, Shinji Makino1,2,3,4,5.   

Abstract

Rift Valley fever phlebovirus (RVFV) has a single-stranded, negative-sense RNA genome, consisting of L, M, and S segments. The virion carries two envelope glycoproteins, Gn and Gc, along with ribonucleoprotein complexes (RNPs), composed of encapsidated genomes carrying N protein and the viral polymerase, L protein. A quantitative analysis of the profile of viral RNA segments packaged into RVFV particles showed that all three genomic RNA segments had similar packaging abilities, whereas among antigenomic RNA segments, the antigenomic S RNA, which serves as the template for the transcription of mRNA expressing the RVFV virulence factor, NSs, displayed a significantly higher packaging ability. To delineate the factor(s) governing the packaging of RVFV RNA segments, we characterized the interactions between Gn and viral RNPs in RVFV-infected cells. Coimmunoprecipitation analysis demonstrated the interaction of Gn with N protein, L protein, and viral RNAs in RVFV-infected cells. Furthermore, UV-cross-linking and immunoprecipitation analysis revealed, for the first time in bunyaviruses, the presence of a direct interaction between Gn and all the viral RNA segments in RVFV-infected cells. Notably, analysis of the ability of Gn to bind to RVFV RNA segments indicated a positive correlation with their respective packaging abilities and highlighted a binding preference of Gn for antigenomic S RNA, among the antigenomic RNA segments, suggesting the presence of a selection mechanism for antigenomic S RNA incorporation into infectious RVFV particles. Collectively, the results of our study illuminate the importance of a direct interaction between Gn and viral RNA segments in determining their efficiency of incorporation into RVFV particles. IMPORTANCE Rift Valley fever phlebovirus, a bunyavirus, is a mosquito-borne, segmented RNA virus that can cause severe disease in humans and ruminants. An essential step in RVFV life cycle is the packaging of viral RNA segments to produce infectious virus particles for dissemination to new hosts. However, there are key gaps in knowledge regarding the mechanisms that regulate viral RNA packaging efficiency in bunyaviruses. Our studies investigating the mechanism of RNA packaging in RVFV revealed the presence of a direct interaction between the viral envelope glycoprotein, Gn, and the viral RNA segments in infected cells, for the first time in bunyaviruses. Furthermore, our data strongly indicate a critical role for the direct interaction between Gn and viral RNAs in determining the efficiency of incorporation of viral RNA segments into RVFV particles. Clarifying the fundamental mechanisms of RNA packaging in RVFV would be valuable for the development of antivirals and live-attenuated vaccines.

Entities:  

Keywords:  RNA-protein interaction; Rift Valley fever phlebovirus; viral RNA packaging

Mesh:

Substances:

Year:  2021        PMID: 33952635      PMCID: PMC8223960          DOI: 10.1128/JVI.00429-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Mechanism of tripartite RNA genome packaging in Rift Valley fever virus.

Authors:  Kaori Terasaki; Shin Murakami; Kumari G Lokugamage; Shinji Makino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH.

Authors:  Markus Kainulainen; Matthias Habjan; Philipp Hubel; Laura Busch; Simone Lau; Jacques Colinge; Giulio Superti-Furga; Andreas Pichlmair; Friedemann Weber
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 3.  The Envelope Proteins of the Bunyavirales.

Authors:  Pablo Guardado-Calvo; Félix A Rey
Journal:  Adv Virus Res       Date:  2017-04-08       Impact factor: 9.937

4.  Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.

Authors:  M Bouloy; C Janzen; P Vialat; H Khun; J Pavlovic; M Huerre; O Haller
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.

Authors:  Tetsuro Ikegami; Sungyong Won; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation.

Authors:  Donald D Raymond; Mary E Piper; Sonja R Gerrard; Janet L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

7.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  The cytoplasmic tail of hantavirus Gn glycoprotein interacts with RNA.

Authors:  Tomas Strandin; Jussi Hepojoki; Hao Wang; Antti Vaheri; Hilkka Lankinen
Journal:  Virology       Date:  2011-07-31       Impact factor: 3.616

10.  Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments.

Authors:  Paul J Wichgers Schreur; Jeroen Kortekaas
Journal:  PLoS Pathog       Date:  2016-08-22       Impact factor: 6.823

View more
  2 in total

1.  Time-Resolved Analysis of N-RNA Interactions during RVFV Infection Shows Qualitative and Quantitative Shifts in RNA Encapsidation and Packaging.

Authors:  Miyuki Hayashi; Eric P Schultz; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Viruses       Date:  2021-12-02       Impact factor: 5.048

Review 2.  How Viruses Use the VCP/p97 ATPase Molecular Machine.

Authors:  Poulami Das; Jaquelin P Dudley
Journal:  Viruses       Date:  2021-09-21       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.